UK-US pharmaceuticals deal to safeguard medicines access
NHS patients will benefit from a trade deal between the UK and the US, which will secure and expand access to drugs, safeguard our medicines supply chain, and drive investment. The deal – part of the UK-US Economic Prosperity Deal – sees the UK become the only country in the world to secure a zero percent tariff on pharmaceuticals to the US – protecting UK-based manufacturing and cementing our place as a world leader for life sciences investment. The deal will also secure preferential terms for the UK’s med tech exports meaning no additional tariffs.